Pinned Tweet
Our existence is merely a result of non-existence. One cannot possibly exist without the other, just as light cannot exist without darkness, nor happiness without sadness.
26
Our drive to live and function is derived from the unknown. An omniscient being would simply have no desires, and hence no path nor direction or reason to live.
18
Thrilled to get my hands on this custom Xbox console auctioned off via a collaboration between @XboxANZ, @CureCancerAu, and @GameOn_Cancer The design draws inspiration from @aruthak tumour mapping approach using @AkoyaBio spatial analysis technology.
Luke T. Quigley retweeted
Want to learn about #tertiarylymphoidstructures (TLSs) in solid tumours? Join us for this webinar to hear @JessDGDuarte from @ONJCRI present the protocol for the in situ interrogation & characterization of TLSs in human/murine tissue sections. https://xitter.gq/t.co/Wo9WUqhf3P
Luke T. Quigley retweeted
Absolutely thrilled to finally share our @STARProtocols article for the identification and grading of tertiary lymphoid structures in human and murine fixed tissue sections using mIHC.
star-protocols.cell.com/prot… – at Yulara, Northern Territory
Just posted a photo @ Olivia Newton-John Cancer Wellness & Research Centre instagram.com/p/Cf2_ObEviG6/…
Hi All!
For the fourth year running I’ll be undertaking the Dry July challenge!
Follow this link if you’d like to drop a donation: dryjuly.com/users/luke-quigl…
(Also, remember that any donations over $2 are tax deductible!!)
3
Interested in investigating Gamma Delta T cells in FFPE tumour tissue? Check out our newest publication right here!
Check out our recent multispectral immunohistochemistry protocol to investigate gamma-delta T cells and butyrophilin molecules in the tumour microenvironment. @ONJ_TILs @LukeTQuigley @ETavancheh @ONJCRI explorationpub.com/Journals/…
1
Just posted a photo @ Olivia Newton-John Cancer Wellness & Research Centre instagram.com/p/Cdmzp85PI4f/…
Privileged to be able to contribute data to this high-profile multi centre phase 2 clinical trial investigating efficacy of combination immunotherapy in patients with rare gynaecological malignancies.
jitc.bmj.com/content/9/11/e0…
1
2
Another successful study published in the International Journal of Molecular Sciences. Always a pleasure collaborating with experts in the field of immunology. @ONJ_TILs @IJMS_MDPI @ONJCRI @JessDGDuarte
Happy to share our latest publication on the Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies mdpi.com/1317880 #mdpiijms via @IJMS_MDPI @LukeTQuigley @ONJ_TILs
1
For the third consecutive year I’ll once again be participating in Dry July to raise money for people affected by cancer. Please support me so that we can improve the lives of these patients as well as their families and friends. dryjuly.com/users/luke-quigl…
2
Another addition to @ONJ_TILs growing list of publications and a first for myself! A big shoutout to all those who worked so tirelessly and meticulously to produce this quality paper, namely @JessDGDuarte who went above and beyond as per usual.
Excited to share our recent work identifying Ropporin-1 and 1B as compelling novel therapeutic antigen targets in melanoma #mdpicancers via @Cancers_MDPI - mdpi.com/2072-6694/13/8/1805
1
4
Luke T. Quigley retweeted
Congrats to our students Josh (@JoshuaAdalin1) and Luke (@LukeQuigley14) for completing their Honours degrees with H1s! We couldn’t be prouder! #Irresistibleimmunologists @ONJCRI







